EPIDERMAL GROWTH FACTOR RECEPTOR
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung or head & neck cancers that have specific EGFR mutations. The drug is a bispecific antibody designed to target cancer cells more precisely. The main goals are to check safety, find the r…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Spinal fluid chemo combo shows promise for advanced lung cancer
Disease control Recruiting nowThis phase 2 trial tests a combination of pemetrexed (given into the spinal fluid) and a tyrosine kinase inhibitor for people with a specific type of lung cancer (EGFR-mutant NSCLC) that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis) after the d…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can surgery or radiation boost lung cancer control after targeted therapy?
Disease control Recruiting nowThis study looks at whether adding surgery or radiation to the main tumor can help people with advanced EGFR-mutant lung cancer who have already responded to a combination of osimertinib and chemotherapy. About 70 adults will receive local therapy and be followed to see how long …
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New scan could reveal hidden aggression in brain tumors
Knowledge-focused Recruiting nowThis study tests a new combined MRI and PET scan that measures how active brain tumor cells are by looking at their energy use (glycolysis). Researchers will take small tissue samples during surgery to check if the scan matches the tumor's actual biology. The goal is to better id…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC